ENVALITH
東北化学薬品株式会社 logo

TOHOKU CHEMICAL CO.,LTD.

7446Standard MarketWholesale Trade

東北化学薬品株式会社 logo
TOHOKU CHEMICAL CO.,LTD.7446
Reference Indicators

Market Cap

46¥100M

P/E (Forecast)

10.0x

P/B

0.5x

Dividend Yield (Forecast)

2.20%

ROE

5.6%

EV/EBITDA

5.8x
Financial Summary
Unit: ¥M
Item
2021Sep 2021
2022Sep 2022
2023Sep 2023
2024Sep 2024
2025Sep 2025
Net Sales
36,22137,33335,09432,15534,442
Cost of Sales
33,04633,86031,75029,01631,156
Gross Profit
3,1753,4723,3443,1393,286
SG&A Expenses
2,4612,5282,5932,7862,767
Operating Income
713944750353518
Non-operating Income
4963677585
Non-operating Expenses
4410218
Ordinary Income
7581,003808407595
Extraordinary Income
24101445
Extraordinary Losses
35303421
Pre-tax Income
748974804380639
Income Taxes
210293238140207
Net Income
516657556237428
EBITDA
8051,035830521684
Gross Margin
8.8%9.3%9.5%9.8%9.5%
Operating Margin
2.0%2.5%2.1%1.1%1.5%
ROA
3.2%3.8%2.9%1.4%2.3%
ROE
8.7%10.2%8.1%3.3%5.6%
Segment Performance
Unit: ¥M
2025
SegmentNet SalesOperating IncomeOperating Margin
インダストリー17,85900.0%
メディカル14,14400.0%
アカデミア・ライフサイエンス2,43900.0%